Journal of Nutrition EB Program 2010 Early Registration

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Swain, J. H.
Right arrow Articles by Hunt, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Swain, J. H.
Right arrow Articles by Hunt, J. R.
© 2007 The American Society for Nutrition J. Nutr. 137:620-627, March 2007


Nutrient Physiology, Metabolism, and Nutrient-Nutrient Interactions

Electrolytic Iron or Ferrous Sulfate Increase Body Iron in Women with Moderate to Low Iron Stores1,2

James H. Swain3, LuAnn K. Johnson and Janet R. Hunt*

USDA, Agricultural Research Service, Grand Forks Human Nutrition Research Center, Grand Forks, ND 58202

* To whom correspondence should be addressed. E-mail: jhunt{at}gfhnrc.ars.usda.gov.

Commercial elemental iron powders (electrolytic and reduced iron), as well as heme iron supplements, were tested for efficacy in improving the iron status of women. In a randomized, double-blind trial, 51 women with moderate to low iron stores received daily for 12 wk: 1) placebo, 2) 5 mg iron as heme iron or 50 mg iron as 3) electrolytic iron, 4) reduced iron, or 5) FeSO4. Treatments were provided in 2 capsules (heme carrier) and 3 wheat rolls (other iron sources). Differences in iron status, food nonheme iron absorption, and fecal properties were evaluated. Body iron, assessed from the serum transferrin receptor:ferritin ratio, increased significantly more in subjects administered FeSO4 (127 ± 29 mg; mean ± SEM) and electrolytic (115 ± 37 mg), but not the reduced (74 ± 32 mg) or heme (65 ± 26 mg) iron forms, compared with those given placebo (2 ± 19 mg). Based on body iron determinations, retention of the added iron was estimated as 3.0, 2.7, 1.8, and 15.5%, in the 4 iron-treated groups, respectively. Iron treatments did not affect food iron absorption. The 50 mg/d iron treatments increased fecal iron and free radical–generating capacity in vitro, but did not affect fecal water cytotoxicity. In subjects administered FeSO4, fecal water content was increased slightly but significantly more than in the placebo group. In conclusion, electrolytic iron was ~86% as efficacious as FeSO4 for improving body iron, but the power of this study was insufficient to detect any efficacy of the reduced or heme iron within 12 wk. With modification, this methodology of testing higher levels of food fortification for several weeks in healthy women with low iron stores has the potential for economically assessing the efficiency of iron compounds to improve iron status.








Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2007 by American Society for Nutrition